Secretory phospholipase A2 potentiates glutamate-induced rat striatal neuronal cell death in vivo

Neuroscience Letters

Volumn 274, Issue 3, 1999, Pages 167-170

  Kolko, Miriam ^a   Bruhn, Torben ^a   Christensen, Thomas ^a   Lazdunski, Michel ^b   Lambeau, Gérard ^b   Bazan, Nicolas G ^c   Diemer, Nils H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Glutamate; Rat striatum; Secretory phospholipases A2; Synergistic neuronal cell death

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID; PHOSPHOLIPASE A2; SNAKE VENOM; NEUROTOXIN; OXYURANUS SCUTELLATUS TOXIN 2; PHOSPHOLIPASE A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APATHY; ARTICLE; BRAIN INFARCTION; CIRCLING BEHAVIOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENTIATION; ENZYME RELEASE; HEMISPHERE; HISTOPATHOLOGY; INJECTION SITE; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NERVE CELL NECROSIS; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE INJURY; ANIMAL; ANIMAL BEHAVIOR; CELL DEATH; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MICROINJECTION; NERVE CELL; PHYSIOLOGY; SECRETION; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CELL DEATH; CEREBRAL INFARCTION; CORPUS STRIATUM; ELAPID VENOMS; GLUTAMIC ACID; MALE; MICROINJECTIONS; NEURONS; NEUROTOXINS; PHOSPHOLIPASES A; RATS; RATS, WISTAR;

EID: 0032590210     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00709-0     Document Type: Article

References (19)

1. Bazan N.G. Signals, messages and genes in cerebral ischemia: novel sites for neuroprotection. Krieglstein J., Oberpichler-Schwenk H. Pharmacology of Cerebral Ischemia. 1994;3-15 Wissenschaftliche Verlagsgeselschaft mbH, Stuttgart.
2. Bazan N.G. A signal terminator. Nature. 374:1995;501-502.
3. Bazan N.G. Lipid messengers and prostaglandin endoperoxide synthase-2 in neuronal cell death. Welsh M., Ca L., Weir B. Primers in Cerebrovascular Diseases. 1997;193-195 Academic Press, Burlington, MA.
4. Bazan N.G., Allan G. Platelet-activating factor and other bioactive lipids. Ginsberg M.D., Bogousslavsky J. Cerebrovascular Disease, Pathophysiology, Diagnosis and Management (Chapter 37). 1998;532-555 Blackwell Science Publishers, Malden, MA.
5. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
6. 2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J. Lipid Mediat. Cell. Signal. 14:1996;15-23.
7. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
8. Doble A. Excitatory amino acid receptors and neurodegeneration. Therapie. 50:1995;319-337.
9. Gegelashvili G., Schousboe A. High Affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol. 52:1997;6-15.
10. Herrero I.M., Miras-Portugal T., Sanchez-Prieto J. Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation. Nature. 350:1992;163-165.
11. 2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J. Biol. Chem. 271:1996;32722-32728.
12. 2 in dopamine secretion by rat neuronal PC12 cells. J. Lipid Mediat. Cell. Signal. 14:1996;25-31.
13. Lambeau G., Barhanin J., Schweitz H., Qar J., Lazdunski M. Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the Taipan venom. J. Biol. Chem. 264:1989;11503-11510.
14. 2. Trends Pharmacol. Sci. 20:1999;162-170.
15. Landolt H., Bullock R., Fujisawa H., McCulloch J., Miller S. LXXII-13 glutamate diffusion characteristics determine neurotoxicity in the rat brain: 14C glutamate autoradiography. Cereb. Blood Flow Metab. 13 (Suppl. 1):1993;S753.
16. 2 in rat brain after severe forebrain ischemia and in endotoxic shock. Brain Res. 651:1994;353-356.
17. 2 treatment of synaptic membranes: temporally differential effects on agonist and antagonist binding. Brain Res. 66:1992;203-208.
18. 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem. J. 318:1996;701-709.
19. O'Regan M.H., Smith-Babour M., Perkins L.M., Phillis J.W. A possible role for phospholipases in the release of neurotransmitter amino acids from ischemic rat cerebral cortex. Neurosci. Lett. 185:1995;191-194.